Japanese Patent Application for Duchenne Muscular Dystrophy Curatives

We have filed a patent application for the Duchenne muscular dystrophy therapeutic molecule (X-0112) with the Japan Patent Office on March 11, 2020, and report on it (Japanese Patent Application 2020-41637). This patent application was made using a subsidy from the Chiba City Industrial Promotion Foundation to a patent support project (Chisanzai No. 533).